Lupin Receives USFDA Approval for Generic Pitolisant Tablets to Treat Sleepiness
Pharmaceutical company Lupin has received final approval from the US Food and Drug Administration (USFDA) for its generic Pitolisant tablets in 4.45 mg and 17.8 mg strengths. These tablets are approved as bioequivalent to Wakix, a prescription medicine by Harmony Biosciences used to treat excessive daytime sleepiness. The approval follows Lupin's Abbreviated New Drug Application and allows the company to market the generic version in the US.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (53/100). Lens Score 37/100.
Outlets measured: economictimes, news18, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 17 Aug, 07:41 am. Other outlets followed.